| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, July 2008, p. 4261-4274, Vol. 28, No. 13
0270-7306/08/$08.00+0 doi:10.1128/MCB.02252-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
Marion Bouchecareilh,2
David L. Baillie,3
Daniel Boismenu,4
Dalia Halawani,5
Martin Latterich,5 and
Eric Chevet1,2,6*
Department of Surgery, McGill University, Montreal, QC, Canada,1 INSERM, U889, Team Avenir, Bordeaux, France,2 Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada,3 McGill University and Génome Quebec Innovation Centre, Montreal, QC, Canada,4 Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada,5 University Bordeaux 2, Bordeaux, France6
Received 20 December 2007/ Returned for modification 7 January 2008/ Accepted 10 April 2008
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Under basal conditions, these integrated mechanisms maintain the ER protein load in equilibrium with ER's folding and export capacities. However, if one of those components is dysfunctional, the entire chain reaction is perturbed and ER homeostasis is disrupted. This leads to an increased amount of improperly folded proteins, which accumulate within the ER. As a mechanism for adaption to this phenomenon, cells have evolved the unfolded protein response (UPR), which aims at restoring ER homeostasis (38, 41) by (i) attenuating protein translation, (ii) increasing ER folding capacity, (iii) increasing ERAD capacity, and (iv) triggering cell death if ER homeostasis is not restored. This stress response is regulated by the activation of three ER resident proximal sensors, which constitute the three arms of the UPR: inositol-requiring enzyme 1 (IRE-1), activating transcription factor 6 (ATF-6), and protein kinase RNA-like ER kinase (PERK) (38, 41).
Another mechanism regulating ER content is mediated by the export machinery. For instance, activation of the UPR was shown to induce the expression of the small G protein SAR-1, a member of the COPII protein complex (28, 40, 43). Moreover, expression of a dominant negative SAR-1 induces the accumulation of proteins in the ER (28, 40, 43), probably leading to the saturation of ER folding capacity. In addition to the role of SAR-1 in the regulation of ER protein load, other GTPases of the RAS superfamily were found to play a role in either organelle maintenance/biogenesis (2, 24) or endomembrane signaling (33-35).
These observations led us to postulate that small GTP binding proteins of the RAS superfamily may represent a master regulatory component of ER homeostasis. To test this hypothesis, we investigated the involvement of these GTPases in the activation of the UPR using RNA interference (RNAi) in Caenorhabditis elegans. This experimental system constitutes a powerful model in which the three UPR arms are conserved and which contains over 60 conserved GTPases of the RAS superfamily. Based on the analysis of a GTPase family subset, our results indicate the specific roles of members of the Rho family of GTPases in the transcriptional activation of UPR target genes. We found that this is possibly regulated through the presence of CRP-1 in a complex with the AAA+ ATPase CDC-48. We demonstrate physical and genetic interactions between CRP-1 and CDC-48 and consequently delineate a novel signaling component physically linking ER stress and transcriptional regulation in metazoans.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Drug induction and GFP quantification.
ER stress level was measured using transgenic worms expressing green fluorescent protein (GFP) under the control of various ER stress promoters. Synchronized L1 populations expressing the different ER stress GFP reporters were grown on standard nematode growth medium (NGM) plates. L4 stage worms were then transferred on NGM plates containing dimethyl sulfoxide as control, 5 µg/ml tunicamycin (TM), 5 mM L-azetidine-2-carboxylic acid (AZC), 1 mM dithiothreitol (DTT), or 1 µM thapsigargin (TG) for 5 h at 20°C. Fluorescence quantification was performed using two different methods. Entire worm populations were analyzed using the Copas Biosort (Union Biometrica) (11), which provided an average fluorescence level for the entire worm population (n
1,000). These results were correlated with an observation-based counting method using fluorescence microscopy in which worms were classified in three groups of (i) low, (ii) medium, and (iii) high levels of fluorescence. At least 100 worms were counted per strain and condition in triplicate by at least two independent investigators. Moreover, to validate the counting methodology, a blinded evaluation of fluorescence was correlated with an immunoblot using anti-GFP antibodies on worm lysates. As expected, the highest signal observed by immunoblotting correlated with the highly fluorescent worm population.
Tissue localization. Expression profiles were analyzed using GFP-reporter transgenic worms (19). Following a 5-h treatment with 5 µg/ml TM at 20°C, living worms were mounted on agarose pads in M9 buffer containing 1 mM levamisole (Sigma). Fluorescence emission from living worms was observed using an Axiovert-200 microscope (Zeiss), and images were analyzed using Northern Eclipse, version 6.0 (Empix Imaging, Mississauga, Ontario, Canada).
RNAi. All RNAi experiments were carried out using a feeding procedure described previously (21). RNAi constructs were either cloned from a C. elegans cDNA library (de novo) or retrieved from the C. elegans ORFeome collection, version 1.1 (37), using the Gateway technology (Invitrogen). For primers used for de novo cloning, see Table S1 in the supplemental material. GTPase open reading frames (ORFs), without ATG, and approximately 500 base pairs of the cdc-48.1 (C06A1.1) and xbp-1 (R74.3) genes were amplified by PCR using Platinum Taq high-fidelity DNA polymerase (Invitrogen) and the following amplification scheme: denaturation at 94°C for 40 s, annealing at 60°C for 40 s, and elongation at 72°C for 1 min for 35 cycles. These PCR products were polyethylene glycol precipitated and recombined into pDONR201 using the Gateway BP Clonase (Invitrogen). These entry clones were subsequently recombined, using LR Clonase, into Gateway-compatible pL4440 vector and transformed into HT115(DE3) bacteria. Isolated transformant bacteria were grown for 12 h at 37°C in Luria-Bertani medium supplemented by 100 µg/ml ampicillin. Bacteria were spotted on NGM plates containing 1 mM IPTG (isopropyl-β-D-thiogalactopyranoside) and 100 µg/ml ampicillin, dried, and induced overnight at room temperature. Synchronized L1 worm populations were transferred to these plates and treated for three days. L4 worms were then transferred to new RNAi plates containing or not 5 µg/ml TM, and fluorescence levels were analyzed as described above, following 5 hours of incubation at 20°C.
ORF cloning, expression, and pull-down affinity purification. Recombinant C. elegans GST-CRP-1 and GST-CDC-42 and mouse His6-p97/VCP/CDC-48 (which displays 76% identity with CeCDC-48) proteins were expressed in Escherichia coli as previously described (8, 23) and purified using glutathione-Sepharose 4B or nickel-nitrilotriacetic acid (NTA)-agarose, respectively. The ORFs encoding CDC-48.1, CDC648.2, and HIM-6 were amplified by reverse transcription-PCR (RT-PCR) using the indicated primers (see Table S1 in the supplemental material) from C. elegans total RNA. The amplified PCR products were cloned by recombination into the pDONR201 vector using the Gateway technology (Invitrogen). The entry vectors generated were then used to recombine the specific ORFs into His6-Nterm or Strep tag-Nterm prokaryotic expression vectors. These were then transformed into DH5a bacteria. Five individual colonies were picked and pooled, and plasmid DNA was amplified and transformed into BL21 cells. Recombinant proteins were produced in BL21 cells following a 3-h induction using either 1 mM IPTG or 0.2 µg/ml tetracycline. Protein lysates were either directly frozen or directly subjected to affinity purification as recommended by the manufacturers. For one set of experiments (see Fig. 4), we used bacterial lysate expressing recombinant proteins. In these conditions, GST-CRP-1 or GST-CDC-42 (in equal amounts) was mixed with mouse His6-p97/VCP/CDC-48-expressing bacterial lysate and the mixture was incubated for 2 hours at 4°C. GST pull-down was then carried out on bacterial lysate using glutathione-Sepharose 4B resin (GE Biosciences). Following incubation for an additional hour at 4°C, beads were washed six times with phosphate-buffered saline and resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were revealed using Coomassie blue R250 staining. His6 pull-down was carried out on N2 or crp-1–/– (ok685) allele strains mixed with purified His6-p97/VCP/CDC-48 proteins for 2 hours at 4°C. Complexes were purified using Ni-NTA-agarose (Qiagen) and resolved by SDS-PAGE. Gels were then transferred on nitrocellulose membranes and subjected to standard immunoblot protocols using either mouse anti-p97/VCP/CDC-48 (Abnova) or hen anti-CRP-1 antibodies (HyperOmics Farma, Inc., Montreal, QC, Canada). For the other set of experiments (see Fig. 5), purified proteins (1 µg) were incubated with 10 mM Tris, pH 7.4, and 100 mM NaCl (in the presence or not of 10 µM GTP and ATP) for 2 h at 4°C and pulled down with beads for 45 min under rotation at 4°C. Following five washes using the same buffer as above but containing 0.5% Triton X-100, the beads were resuspended in 2x Laemmli sample buffer, resolved by electrophoresis, and immunoblotted using anti-glutathione S-transferase (GST; Cellular Signaling) or anti-Strep tag (Qiagen) antibodies.
|
|
Data analyses. The human ortholog of each hit identified in the CRP-1 pull-down was retrieved from NCBI, ENSEMBL, or other large sequence repositories when existing or available. The corresponding list was then analyzed using the STRING suite (46, 47) to evaluate the potentially existing functional interactions between proteins found in the CRP-1 complex. We also added a subnetwork including the first-degree genetic or physical interactor of His6-p97/VCP/CDC-48. The resulting scale-free functional interaction network was then annotated using the Medusa program (16).
TM sensitivity assay. N2 worms and mutant strains were treated using the alkaline hypochlorite method (0.5 M NaOH, H2O, and 0.8% bleach) to isolate embryos. Eggs were hatched overnight in M9 medium (40 mM Na2HPO4, 20 mM KH2PO4, 8 mM NaCl, 20 mM NH4Cl) to obtain an L1-synchronized population. L1 worms were transferred onto NGM plates containing various concentrations of TM (0, 2, 5, or 10 µg/ml) and seeded on HT115 cells expressing or not double-stranded RNA (dsRNA) for the target genes (see "RNAi" for conditions). The developmental stage was analyzed after 24 and 48 h at 20°C, and the percentages of L1 larvae and dead worms over the total population were determined and reported.
RT-PCR analyses. Worms (N2 or crp-1–/–) were treated or not with 5 µg/ml TM and 2 mM DTT for 5 h or 10 mM NaN3 for 90 min. They were then collected and lysed using Trizol (Invitrogen). Total RNA was then extracted as recommended by the manufacturer and reverse transcribed using the Superscript III kit (Invitrogen). PCR products were then amplified using the primers described in Table S1 in the supplemental material within the linear part of the amplification curve, resolved on agarose gels, and visualized following ethidium bromide staining. Transcript expression was normalized to that of ama-1.
| RESULTS |
|---|
|
|
|---|
|
ER stress-responsive promoters are specifically activated upon treatment with different ER stress inducers. To determine if the induction of fluorescence observed in the three most responsive GFP-reporter strains was TM specific, we treated transgenic animals using various chemicals known to induce ER stress in cultured mammalian cells. Worms were exposed to four different agents, including TM, that act differentially on the ER but ultimately lead to ER stress. AZC is a proline analogue which causes defects in protein conformation when integrated into the polypeptide chain (10). DTT is a reducing agent that affects the ER lumen oxidative environment (4), and, finally, TG is a Ca2+-ATPase (SERCA) inhibitor that causes ER Ca2+ depletion (39). As shown in Fig. 2, the three GFP reporter strains tested responded differentially to the four ER stress inducers selected. In our experimental setup, TM was the strongest ER stress inducer for the pckb-2::gfp, phsp-4::gfp, and ptag-320::gfp strains with, respectively, 78%, 80%, and 22% of the worm population expressing a high level of fluorescence following a 5-hour treatment. AZC and DTT had mainly the same impact on the three reporters, with almost 49% of worms expressing high fluorescence in the pckb-2::gfp strain, 28% in the phsp-4::gfp strain, and less than 20% in the ptag-320::gfp strain. Finally, TG had a higher level of fluorescence induction in the pckb-2::gfp strain, with 61% of the worm population expressing high fluorescence. These results show that pckb-2::gfp is the reporter which presents the highest and most homogenous response to diverse ER stress treatments. In addition, they indicate that, in our experimental settings, TM represents the most universal ER stress inducer. For these reasons, we selected the pckb-2::gfp reporter to identify, using RNAi, new ER signaling regulators and TM to induce ER stress in C. elegans.
|
|
The two other categories included GTPases for which alteration of expression levels had significant effects on ER stress-mediated pckb-2::gfp activation under basal conditions or following treatment. Representative results obtained for these GTPases are shown in Fig. 3A. In the third category, we identified one GTPase, SAR-1, whose silencing led to an activation of pckb-2::gfp under basal conditions. This is consistent with the previous observations that SAR-1 was implicated in membrane transport from the ER to the Golgi apparatus (43). In addition, our results suggest that disruption of this transport would inhibit protein progression from the ER (43) and consequently induce the UPR. The fourth category contains two GTPases, CDC-42 and CRP-1, whose silencing prevented pckb-2::gfp activation after TM exposure. CDC-42 is a small GTPase that regulates actin dynamics and has also been involved in Golgi-to-ER vesicle trafficking events in mammalian cells (25). CRP-1 is a small G protein which clustered with the Rho subfamily according to its amino acid sequence and showed 45% identity to CDC-42 (19) (Table 1). We previously showed that CRP-1 is implicated in the regulation of membrane trafficking in intestinal cells (19) and that CRP-1 RNAi specifically targets CRP-1 expression (see Fig. S1 in the supplemental material). Quantification of total fluorescence of a worm population clearly showed that crp-1 silencing significantly led to a reduced activation of the pckb-2::gfp reporter under ER stress conditions (Fig. 3B). Our results suggest that both CRP-1 and CDC-42 may be specifically involved in the transmission/establishment of ER stress signals in C. elegans.
|
CDC-48 has been implicated in the ERAD pathway and in ER membrane fusion (13) and has been identified as a regulator of the ER stress response (48). We confirmed the interaction between CRP-1 and CDC-48 using both GST-CRP-1 and the mouse His6-P97/VCP/CDC-48 fusion protein expressed in E. coli. In this experiment, E. coli lysates containing either GST-CRP-1 or GST-CDC-42 were mixed with His6-P97/VCP/CDC-48-containing lysate followed by pull-down using glutathione-Sepharose beads. As shown in Fig. 4B, P97/VCP/CDC-48 was found in the CRP-1 complex, thus confirming the mass spectrometry analyses. Interestingly, no interaction between P97/VCP/CDC-48 and CDC-42 was detected under these conditions (Fig. 4B). The reverse experiment was also carried out using N2 and CRP-1–/– (allele ok685) (19) worm lysates, which were pulled-down using His6-P97/VCP/CDC48 immobilized on Ni-agarose beads (Fig. 4B). As expected, a complex between P97/VCP/CDC-48 and CRP-1 was observed in wild-type animals but not in the CPR-1–/– worm lysates. The hypothesis supporting a functional interaction between CRP-1 and CDC-48 was also reinforced using cdc-48.1 silencing in pckb-2::gfp reporter worms. As observed for crp-1, reduction of cdc-48.1 expression led to an inhibition of TM-induced pckb-2::gfp reporter activation (Fig. 4C). This phenotype suggests that pckb-2::gfp activation by TM requires both CRP-1 and CDC-48.1.
Among the proteins identified by mass spectrometry, two other hits presented some interest. Indeed, ATM-1 (Y48G1BL.2) and HIM-6 (T04A11.6) are, respectively, an ortholog of the human protein kinase ATM and the human Bloom syndrome helicase (BLM), a RecQ-like ATP-dependent DNA helicase. BLM was shown to be a direct substrate of ATM, and both proteins are required for optimal repair during DNA replication (1, 36). Recently, p97/VCP/CDC-48 was also shown to be a direct substrate of ATM kinase, but the physiological function of this interaction remains unclear (26). Finally, it was shown that p97/VCP/CDC-48 interacted with another RecQ helicase, WRN, and modulated its localization and functions (18). As a consequence, we postulated that we might have purified a complex of proteins implicated in DNA repair, DNA remodeling, or transcriptional processes and containing at least CRP-1, CDC-48, and ATM-1.
Using the STRING program suite (http://string.embl.de/), a database for the retrieval of known and predicted gene/proteins interactions (46, 47), we built a network based on the human orthologs of the C. elegans proteins identified in the CRP-1 GST pull-down (Fig. 4D, white nodes; see Table S3 in the supplemental material). Interestingly, 9 out of the 20 proteins identified by mass spectrometry (Fig. 4D, white nodes) were found to belong to a specific subnetwork implicated in DNA processes (Fig. 4D, black nodes) and including the transcriptional activator p53, ATM, BLM, and P97/VCP/CDC-48. In contrast, none of the proteins found in complex with CRP-1 belonged to the other p97/VCP/CDC-48 subnetwork functionally related to ERAD or membrane fusion (Fig. 4D, gray nodes). In addition, when we attempted to identify other potential functional networks in which proteins found in the CRP-1 GST pull-down could be enriched, no significant other group could be generated (data not shown). This specific functional enrichment further supported the idea that CRP-1 might interact with a protein complex implicated in DNA remodeling/transcription.
Physical interactions regulating the complex including CRP-1, CDC-48, and HIM-6. To further evaluate the relevance of a protein complex including CRP-1, HIM-6, and CDC-48, we evaluated the in vitro interactions between these three proteins. To this end, we used the previously described GST-CRP-1 as well as bacterial recombinant HIM-6 and CDC-48.1, both N-terminally tagged by either six histidine residues or a Strep tag and produced as described in Materials and Methods. We established the existence of six possible interactions to be tested in vitro. We first tested the direct interactions between CRP-1 and HIM-6 and between CRP-1 and CDC-48.1. As shown in Fig. 5A, CRP-1 did not directly bind to HIM-6 but, as expected from the results obtained in Fig. 4, directly interacted with CDC-48.1 (similar results were obtained with CDC-48.2 [data not shown]). We then evaluated the association between HIM-6 and CDC-48.1. To this end, six-His-tagged CDC-48.1 or HIM-6 was incubated in the presence of Strep-tagged HIM-6 or CDC-48.1, respectively; the mixture was then pulled-down using Ni-NTA-agarose beads and immunoblotted using anti-Strep tag antibodies. These experiments revealed that HIM-6 directly associated with CDC-48.1 (Fig. 5B). This result was not that surprising, as P97, the mammalian ortholog of CDC-48, binds to the Werner syndrome RecQ helicase, which is homologous to BLM, the mammalian ortholog of HIM-6. In an attempt to test for the existence of a ternary complex, we incubated GST-CRP-1 with Strep-tagged HIM-6 and increasing concentrations of His6-CDC-48.1 (Fig. 5C). The mixture was then subjected to a pull-down using glutathione-Sepharose beads and immunoblotted using anti-Strep tag antibodies. The analysis revealed the existence of a ternary complex comprising CRP-1, HIM-6, and CDC-48, with the last bridging the two others (Fig. 5C). This allowed us to build an interaction model where CRP-1 is in complex with HIM-6 through interaction with CDC-48. In this model, ATM-1 could play a regulatory role by phosphorylating both CDC-48 and HIM-6 since the mammalian orthologs of these proteins are established ATM substrates (26).
C. elegans resistance to ER stress is controlled though genetic interactions between crp-1, cdc-48.1, and atm-1. To evaluate the functional relevance of such a complex, we hypothesized that CRP-1, CDC-48.1, and ATM-1 could constitute a functional protein complex involved in an ER stress-mediated transcriptional regulatory pathway. We then postulated that mutations in these proteins would cause defects in their ER stress-adaptive capacity. Consequently, we tested the susceptibility of wild-type and knockout strains subjected to treatments with increasing TM concentrations. Under basal conditions, wild-type worms (N2) as well as crp-1 (ok685), cdc-48.1 (tm544), and atm-1 (gk186) knockout strains developed normally and the growth rate of wild-type (N2) worms was not affected until the concentration of TM reached 5 µg/ml (Fig. 6A and B). At this concentration, less than 20% of the N2 worms failed to develop to adults. In contrast, crp-1–/–, atm-1–/–, and to a lesser extent cdc-48.1–/– knockout strains were more sensitive to TM than N2 worms (Fig. 6A and B). At 2 µg/ml of TM, more than 60% of all the crp-1–/– mutants and 30% of the atm-1–/– mutants were arrested at the L1 larval stages compared to less than 1% of wild-type worms. Cdc-48.1–/– mutants displayed a similar phenotype at a 5-µg/ml concentration of TM, where 70% of cdc-48.1–/– mutants failed to develop to adults compared to 20% of wild-type animals. These results suggest that crp-1, cdc-48.1, and atm-1 are required for worm adaptation to stress conditions and for larva development.
|
Genetic interactions between CRP-1 and the UPR components. In an attempt to further dissect the role of CRP-1 in the ER stress response, we analyzed using RT-PCR the expression of seven genes, hsp-4, srp-7, dnj-27, cht-1, ckb-2, F22E5.6, and xbp-1, that were previously reported to be specifically regulated by the UPR (42, 45). These genes were selected on the basis of two transcriptome analyses (42, 45). The expression of the corresponding mRNAs was normalized using the expression levels of ama-1, previously reported not to be a UPR target (22). To evaluate the expression levels of the mRNAs, N2 or crp-1–/– worms were treated with TM, DTT (oxidative stress), or sodium azide (hypoxia) as described in Materials and Methods. Interestingly, the absence of CRP-1 did not significantly affect the expression levels of srp-7. More importantly, a differential response was observed for the other genes, with attenuated expression in crp-1–/– worms of xbp-1 and ckb-2 and increased expression of hsp-4 and F22E5.6 (Fig. 7 A and B). The response also varied depending on the stress applied to the worms, as observed in Fig. 2. In addition, we assessed the effect on the splicing of xbp-1 mRNA of the above-mentioned stresses. mRNA splicing was slightly attenuated upon TM treatment in crp-1–/– animals but remained unchanged upon treatment with other stressors (Fig. 7C; P < 0.02).
|
|
| DISCUSSION |
|---|
|
|
|---|
In an attempt to identify novel regulators of the UPR, we characterized eight GFP reporters to allow rapid and efficient detection of ER stress in living C. elegans. Only two reporters, pF48E3.3::gfp and pbre-1::gfp, were not responsive to TM. Besides a per se nonresponsiveness to ER stress, the lack of induction of these two reporters could be attributed to (i) gene expression exclusively in tissues or cells that are less exposed to TM, (ii) fluorescence levels too low to be detected using the Copas Biosort, or finally (iii) the region cloned to construct the GFP reporter not including all the regulatory elements required for promoter activation. We selected three specific reporters that were highly induced upon ER stress and displayed major intestinal expression. Interestingly, the activation of the different reporter construct-selected promoters was dependent on the ER stress inducer (TM, AZC, DTT, or TG) used for our experiment, supporting the conservation in C. elegans of a UPR machinery known to be extremely complex and multimodular in mammals (42). To provide functional insights into regulatory mechanisms taking place during UPR activation, we used a reverse genetic approach combining gene silencing and analysis of in vivo GFP reporters upon basal and ER stress conditions. At first, we evaluated the role of 13 GTPases either localized in the ER or along the secretory pathway or implicated in ER-related function to increase the chances of affecting ER stress signaling. The silencing of most of the GTPases did not show any effect on the reporter. Even if the entire reading frames were used to perform the RNAi, we could not exclude the possibility that these negative observations may result from RNAi inefficiency in degrading target mRNAs. Indeed, many factors can dramatically reduce the effectiveness of an RNAi experiment. First, dsRNA introduced into the worms might not be abundant enough to completely degrade the target mRNA. This is particularly true for mRNAs that are highly expressed or which have a low turnover (long half-life). The tissue localization of the GTPase mRNA is also an important factor to consider. Since the GFP reporter used in our experiments was mainly expressed in the worm intestine, GTPases expressed in other tissues might have a lower impact on the activation of this promoter.
Our experimental approach allowed us to identify three GTPases, namely, SAR-1, CDC-42, and CRP-1, as important regulators of ER stress signaling under either basal or stress conditions. Indeed silencing of SAR-1, which belongs to the COPII complex, led to the activation of ER stress under basal conditions. This observation could be explained by the required presence of SAR-1 for protein progression from the ER; the resulting protein accumulation may be sufficient to saturate ER folding capacity and lead to ER stress.
On the other hand, silencing of CDC-42 and CRP-1 prevented TM-induced pckb-2::gfp activation. These proteins are two homologous member of the Rho subfamily of GTPases. We then sought to investigate the molecular mechanisms responsible for this observation. To this end, CRP-1-interacting partners were characterized by CRP-1-GST pull-down followed by mass spectrometry analysis. Integration of these data to a STRING-based (46, 47) functional network representation of CRP-1 partners showed that most of the hits identified were involved in transcriptional and DNA-monitoring/repair processes. We showed that the transcription-regulatory role of CRP-1 also required a direct interaction with the AAA+ ATPase CDC-48.1. It is noteworthy that both genetic and physical interactions between GTPases of the RAS superfamily and AAA ATPases have been reported in the literature to be relevant to specific physiological and pathological mechanisms (12, 44).
CDC-48 is a mostly cytosolic chaperone involved in several cellular pathways, such as organelle maintenance through homotypic membrane fusion of the ER, Golgi apparatus, and nuclear envelope, and degradation of misfolded proteins via ERAD (13). This protein is homologous to the mammalian P97/VCP/CDC-48, which is also found in the nucleus and directly binds to the RecQ domain of Werner syndrome helicase (WRN) (18, 32). Interestingly, when we characterized CRP-1-interacting proteins, we found the C. elegans Bloom syndrome helicase homolog HIM-6, which shows a RecQ domain conserved with that of WRN. Moreover, in the complex, we also detected the ATM-1 kinase, which is known to phosphorylate BLM and VCP in mammalian systems (26). We confirmed that CRP-1 can directly interact with CDC-48 in vitro but not with HIM-6. The CRP-1/HIM-6 complex was made possible by the presence of CDC-48, which bridges those proteins (Fig. 5). The role of ATM-1 in this complex remains to be further investigated. However, as BLM (the HIM-6 mammalian ortholog) and P97/VCP (the CDC-48 mammalian ortholog) are both ATM substrates, this kinase may represent a key regulatory component of the DNA remodeling/transcriptional functions of the complex. As a consequence, we believe that CDC-48 might act as a scaffold to create a new functional complex between HIM-6, CRP-1, and possibly ATM-1, which could in turn activate/inactivate specific transcriptional programs, as evidenced in Fig. 7A and B.
In addition, we propose a novel role for P97/VCP/CDC-48 in the regulation of ER stress. Indeed, this protein could function in parallel (and perhaps independently) to ERAD because (i) none of the CRP-1-interacting partners found in the P97/VCP/CDC-48 functional subnetwork were implicated in ERAD and membrane fusion (Fig. 5D), (ii) these two events are known to occur in different subcellular compartments, with ERAD occurring mainly in the cytosol, whereas the mechanisms identified here are believed to take place in the nucleus, and finally (iii) silencing of P97/VCP/CDC-48-interacting partners involved in ERAD (NPL-4 and UFD-1) leads to lethal phenotypes, which is not the case for HIM-6 and ATM-1 (Fig. 6). The last observation may rely on the fact that either the CDC-48-dependent transcriptional program activated in response to ER stress is dispensable or redundant mechanisms can compensate for the absence of HIM-6 (e.g., WRN-1) or ATM-1 (e.g., ATL-1).
In addition to this evidence, we have demonstrated that crp-1 genetically interacted with atf-6, as the absence of CRP-1 decreased the sensitivity of ATF-6-deficient but not PEK-1-deficient worms to TM (Fig. 8). This suggested that, similar what that occurs in the IRE-1/XBP-1 axis (see Fig. S2 in the supplemental material), the CRP-1/CDC-48/HIM-6 complex is implicated in the regulation of subsets of genes required for ER stress adaptation. This phenomenon could potentially be explained by the substantial redistribution of CRP-1 from punctate structures to more-diffuse areas, which is observed upon TM treatment (see Fig. S3 in the supplemental material). Although the subcellular localization of the complex and its dynamics remain to be fully investigated, our data suggest that TM treatment may alter the localization of CRP-1 and CDC-48 to promote their nuclear localization (see Fig. S3 in the supplemental material) (32) by a yet-undetermined mechanism. In this compartment, a ternary complex between CRP-1, CDC-48, and HIM-6 may form to promote DNA remodeling/gene transcription control. This complex may then be regulated by the activation of the ATM-1 pathway (stabilized or destabilized), as suggested by the observation, made by Partridge and colleagues, that in mammalian cells DNA damage, an ATM activator, promotes the dissociation of the RecQ helicase WRN from the CDC-48 ortholog P97/VCP (32).
Our results unravel the existence of a novel pathway dependent on the GTP binding protein CRP-1 and the AAA+ ATPase CDC-48 which controls a specific UPR-mediated transcriptional response to promote cell adaptation to ER stress. This pathway may be dependent on DNA remodeling mechanisms, as indicated by the complex formed by CRP-1, CDC-48, and the RecQ DNA helicase HIM-6, and may be activated independently of ERAD (Fig. 8E).
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Fond de Recherche en Santé du Québec, INSERM (Avenir), and a Marie Curie reintegration grant to E.C. M.E.C. was a recipient of a FRNTQ Ph.D. studentship.
| FOOTNOTES |
|---|
Published ahead of print on 5 May 2008. ![]()
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
Present address: Dept. of Chemistry, UQAM, Montreal, QC, Canada. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Altan-Bonnet, N., R. Sougrat, and J. Lippincott-Schwartz. 2004. Molecular basis for Golgi maintenance and biogenesis. Curr. Opin. Cell Biol. 16:364-372.[CrossRef][Medline]
3. Bicknell, A. A., A. Babour, C. M. Federovitch, and M. Niwa. 2007. A novel role in cytokinesis reveals a housekeeping function for the unfolded protein response. J. Cell Biol. 177:1017-1027.
4. Braakman, I., J. Helenius, and A. Helenius. 1992. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO J. 11:1717-1722.[Medline]
5. Brenner, S. 1974. The genetics of Caenorhabditis elegans. Genetics 77:71-94.
6. Calfon, M., H. Zeng, F. Urano, J. H. Till, S. R. Hubbard, H. P. Harding, S. G. Clark, and D. Ron. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415:92-96.[CrossRef][Medline]
7. Caruso, M. E., and E. Chevet. 2007. Systems biology of the endoplasmic reticulum stress response. Subcell. Biochem. 43:277-298.[Medline]
8. Caruso, M. E., S. Jenna, S. Beaulne, E. H. Lee, A. Bergeron, C. Chauve, P. Roby, J. F. Rual, D. E. Hill, M. Vidal, R. Bosse, and E. Chevet. 2005. Biochemical clustering of monomeric GTPases of the Ras superfamily. Mol. Cell. Proteomics 4:936-944.
9. Chevet, E., P. H. Cameron, M. F. Pelletier, D. Y. Thomas, and J. J. Bergeron. 2001. The endoplasmic reticulum: integration of protein folding, quality control, signaling and degradation. Curr. Opin. Struct. Biol. 11:120-124.[CrossRef][Medline]
10. Chevet, E., C. A. Jakob, D. Y. Thomas, and J. J. Bergeron. 1999. Calnexin family members as modulators of genetic diseases. Semin. Cell Dev. Biol. 10:473-480.[CrossRef][Medline]
11. Dupuy, D., N. Bertin, C. A. Hidalgo, K. Venkatesan, D. Tu, D. Lee, J. Rosenberg, N. Svrzikapa, A. Blanc, A. Carnec, A. R. Carvunis, R. Pulak, J. Shingles, J. Reece-Hoyes, R. Hunt-Newbury, R. Viveiros, W. A. Mohler, M. Tasan, F. P. Roth, C. Le Peuch, I. A. Hope, R. Johnsen, D. G. Moerman, A. L. Barabasi, D. Baillie, and M. Vidal. 2007. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat. Biotechnol. 25:663-668.[CrossRef][Medline]
12. Evans, K., C. Keller, K. Pavur, K. Glasgow, B. Conn, and B. Lauring. 2006. Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. Proc. Natl. Acad. Sci. USA 103:10666-10671.
13. Halawani, D., and M. Latterich. 2006. p97: the cell's molecular purgatory? Mol. Cell 22:713-717.[CrossRef][Medline]
14. Harding, H. P., and D. Ron. 2002. Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 51(Suppl. 3):S455-S461.[CrossRef][Medline]
15. Hemming, F. W. 1982. Control and manipulation of the phosphodolichol pathway of protein N-glycosylation. Biosci. Rep. 2:203-221.[CrossRef][Medline]
16. Hooper, S. D., and P. Bork. 2005. Medusa: a simple tool for interaction graph analysis. Bioinformatics 21:4432-4433.
17. Hunt-Newbury, R., R. Viveiros, R. Johnsen, A. Mah, D. Anastas, L. Fang, E. Halfnight, D. Lee, J. Lin, A. Lorch, S. McKay, H. M. Okada, J. Pan, A. K. Schulz, D. Tu, K. Wong, Z. Zhao, A. Alexeyenko, T. Burglin, E. Sonnhammer, R. Schnabel, S. J. Jones, M. A. Marra, D. L. Baillie, and D. G. Moerman. 2007. High-throughput in vivo analysis of gene expression in Caenorhabditis elegans. PLoS Biol. 5:e237.[CrossRef][Medline]
18. Indig, F. E., J. J. Partridge, C. von Kobbe, M. I. Aladjem, M. Latterich, and V. A. Bohr. 2004. Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion. J. Struct. Biol. 146:251-259.[CrossRef][Medline]
19. Jenna, S., M. E. Caruso, A. Emadali, D. T. Nguyen, M. Dominguez, S. Li, R. Roy, J. Reboul, M. Vidal, G. N. Tzimas, R. Bosse, and E. Chevet. 2005. Regulation of membrane trafficking by a novel Cdc42-related protein in Caenorhabditis elegans epithelial cells. Mol. Biol. Cell 16:1629-1639.
20. Jenna, S., and E. Chevet. 2007. High-throughput RNAi in Caenorhabditis elegans—from molecular phenotypes to pathway analysis, p. 158. In M. Latterich (ed.), RNAi. Taylor and Francis, New York, NY.
21. Kamath, R. S., A. G. Fraser, Y. Dong, G. Poulin, R. Durbin, M. Gotta, A. Kanapin, N. Le Bot, S. Moreno, M. Sohrmann, D. P. Welchman, P. Zipperlen, and J. Ahringer. 2003. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421:231-237.[CrossRef][Medline]
22. Kapulkin, W. J., B. G. Hiester, and C. D. Link. 2005. Compensatory regulation among ER chaperones in C. elegans. FEBS Lett. 579:3063-3068.[CrossRef][Medline]
23. Lavoie, C., E. Chevet, L. Roy, N. K. Tonks, A. Fazel, B. I. Posner, J. Paiement, and J. J. Bergeron. 2000. Tyrosine phosphorylation of p97 regulates transitional endoplasmic reticulum assembly in vitro. Proc. Natl. Acad. Sci. USA 97:13637-13642.
24. Lazarow, P. B. 2003. Peroxisome biogenesis: advances and conundrums. Curr. Opin. Cell Biol. 15:489-497.[CrossRef][Medline]
25. Luna, A., O. B. Matas, J. A. Martinez-Menarguez, E. Mato, J. M. Duran, J. Ballesta, M. Way, and G. Egea. 2002. Regulation of protein transport from the Golgi complex to the endoplasmic reticulum by CDC42 and N-WASP. Mol. Biol. Cell 13:866-879.
26. Matsuoka, S., B. A. Ballif, A. Smogorzewska, E. R. McDonald III, K. E. Hurov, J. Luo, C. E. Bakalarski, Z. Zhao, N. Solimini, Y. Lerenthal, Y. Shiloh, S. P. Gygi, and S. J. Elledge. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160-1166.
27. McKay, S. J., R. Johnsen, J. Khattra, J. Asano, D. L. Baillie, S. Chan, N. Dube, L. Fang, B. Goszczynski, E. Ha, E. Halfnight, R. Hollebakken, P. Huang, K. Hung, V. Jensen, S. J. Jones, H. Kai, D. Li, A. Mah, M. Marra, J. McGhee, R. Newbury, A. Pouzyrev, D. L. Riddle, E. Sonnhammer, H. Tian, D. Tu, J. R. Tyson, G. Vatcher, A. Warner, K. Wong, Z. Zhao, and D. G. Moerman. 2003. Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harbor Symp. Quant. Biol. 68:159-169.[CrossRef][Medline]
28. Memon, A. R. 2004. The role of ADP-ribosylation factor and SAR1 in vesicular trafficking in plants. Biochim. Biophys. Acta 1664:9-30.[Medline]
29. Moenner, M., O. Pluquet, M. Bouchecareilh, and E. Chevet. 2007. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 67:10631-10634.
30. Mori, K. 2004. Unfolded protein response as a quality control mechanism of proteins. Tanpakushitsu Kakusan Koso 49:992-997. (In Japanese.)[Medline]
31. Otsu, M., and R. Sitia. 2007. Diseases originating from altered protein quality control in the endoplasmic reticulum. Curr. Med. Chem. 14:1639-1652.[CrossRef][Medline]
32. Partridge, J. J., J. O. Lopreiato, Jr., M. Latterich, and F. E. Indig. 2003. DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP. Mol. Biol. Cell 14:4221-4229.
33. Philips, M. R. 2005. Compartmentalized signalling of Ras. Biochem. Soc. Trans. 33:657-661.[CrossRef][Medline]
34. Philips, M. R. 2004. Sef: a MEK/ERK catcher on the Golgi. Mol. Cell 15:168-169.[CrossRef][Medline]
35. Quatela, S. E., and M. R. Philips. 2006. Ras signaling on the Golgi. Curr. Opin. Cell Biol. 18:162-167.[CrossRef][Medline]
36. Rao, V. A., A. M. Fan, L. Meng, C. F. Doe, P. S. North, I. D. Hickson, and Y. Pommier. 2005. Phosphorylation of BLM, dissociation from topoisomerase III
, and colocalization with
-H2AX after topoisomerase I-induced replication damage. Mol. Cell. Biol. 25:8925-8937.
37. Reboul, J., P. Vaglio, J. F. Rual, P. Lamesch, M. Martinez, C. M. Armstrong, S. Li, L. Jacotot, N. Bertin, R. Janky, T. Moore, J. R. Hudson, Jr., J. L. Hartley, M. A. Brasch, J. Vandenhaute, S. Boulton, G. A. Endress, S. Jenna, E. Chevet, V. Papasotiropoulos, P. P. Tolias, J. Ptacek, M. Snyder, R. Huang, M. R. Chance, H. Lee, L. Doucette-Stamm, D. E. Hill, and M. Vidal. 2003. C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nat. Genet. 34:35-41.[CrossRef][Medline]
38. Ron, D., and P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8:519-529.[CrossRef][Medline]
39. Sabala, P., M. Czarny, J. P. Woronczak, and J. Baranska. 1993. Thapsigargin: potent inhibitor of Ca2+ transport ATP-ases of endoplasmic and sarcoplasmic reticulum. Acta Biochim. Pol. 40:309-319.[Medline]
40. Saloheimo, M., H. Wang, M. Valkonen, T. Vasara, A. Huuskonen, M. Riikonen, T. Pakula, M. Ward, and M. Penttila. 2004. Characterization of secretory genes ypt1/yptA and nsf1/nsfA from two filamentous fungi: induction of secretory pathway genes of Trichoderma reesei under secretion stress conditions. Appl. Environ Microbiol. 70:459-467.
41. Schroder, M., and R. J. Kaufman. 2005. The mammalian unfolded protein response. Annu. Rev. Biochem. 74:739-789.[CrossRef][Medline]
42. Shen, X., R. E. Ellis, K. Sakaki, and R. J. Kaufman. 2005. Genetic interactions due to constitutive and inducible gene regulation mediated by the unfolded protein response in C. elegans. PLoS Genet. 1:e37.[CrossRef][Medline]
43. Takeuchi, M., T. Ueda, K. Sato, H. Abe, T. Nagata, and A. Nakano. 2000. A dominant negative mutant of sar1 GTPase inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus in tobacco and Arabidopsis cultured cells. Plant J. 23:517-525.[CrossRef][Medline]
44. Tanaka, H., H. Fujita, H. Katoh, K. Mori, and M. Negishi. 2002. Vps4-A (vacuolar protein sorting 4-A) is a binding partner for a novel Rho family GTPase, Rnd2. Biochem. J. 365:349-353.[CrossRef][Medline]
45. Urano, F., M. Calfon, T. Yoneda, C. Yun, M. Kiraly, S. G. Clark, and D. Ron. 2002. A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response. J. Cell Biol. 158:639-646.
46. von Mering, C., M. Huynen, D. Jaeggi, S. Schmidt, P. Bork, and B. Snel. 2003. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 31:258-261.
47. von Mering, C., L. J. Jensen, M. Kuhn, S. Chaffron, T. Doerks, B. Kruger, B. Snel, and P. Bork. 2007. STRING 7-recent developments in the integration and prediction of protein interactions. Nucleic Acids Res. 35:D358-D362.[CrossRef][Medline]
48. Wojcik, C., M. Rowicka, A. Kudlicki, D. Nowis, E. McConnell, M. Kujawa, and G. N. DeMartino. 2006. Valosin-containing protein (p97) is a regulator of endoplas